NOTTINGHAM ADVISORS, INC. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
NOTTINGHAM ADVISORS, INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2017$54,000
+38.5%
15,9350.0%0.01%
+33.3%
Q2 2017$39,000
+8.3%
15,9350.0%0.01%0.0%
Q1 2017$36,000
+5.9%
15,9350.0%0.01%0.0%
Q4 2016$34,000
-35.8%
15,9350.0%0.01%
-33.3%
Q3 2016$53,000
+6.0%
15,9350.0%0.01%0.0%
Q2 2016$50,000
-10.7%
15,9350.0%0.01%
-10.0%
Q1 2016$56,0000.0%15,9350.0%0.01%0.0%
Q4 2015$56,000
-30.0%
15,9350.0%0.01%
-33.3%
Q3 2015$80,000
-21.6%
15,9350.0%0.02%
-11.8%
Q2 2015$102,000
-8.9%
15,9350.0%0.02%
-5.6%
Q1 2015$112,00015,9350.02%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders